These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18204077)
1. Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility. Zhang K; Yao HP; Wang MH Carcinogenesis; 2008 Mar; 29(3):552-9. PubMed ID: 18204077 [TBL] [Abstract][Full Text] [Related]
2. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase. Wang D; Shen Q; Chen YQ; Wang MH Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985 [TBL] [Abstract][Full Text] [Related]
3. Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells. Wang D; Shen Q; Xu XM; Chen YQ; Wang MH Carcinogenesis; 2005 Jan; 26(1):27-36. PubMed ID: 15447977 [TBL] [Abstract][Full Text] [Related]
4. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase. Ma Q; Zhang K; Guin S; Zhou YQ; Wang MH Mol Cancer; 2010 Nov; 9():307. PubMed ID: 21114864 [TBL] [Abstract][Full Text] [Related]
5. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells. Zhang K; Zhou YQ; Yao HP; Wang MH Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway. Xiangming X; Yun Q; Guoliang Z; Jianjiang L; Lisong T Braz J Med Biol Res; 2011 Jul; 44(7):634-41. PubMed ID: 21655705 [TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. Lipschutz JH; Li S; Arisco A; Balkovetz DF J Biol Chem; 2005 Feb; 280(5):3780-8. PubMed ID: 15569684 [TBL] [Abstract][Full Text] [Related]
8. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Martínez-Estrada OM; Cullerés A; Soriano FX; Peinado H; Bolós V; Martínez FO; Reina M; Cano A; Fabre M; Vilaró S Biochem J; 2006 Mar; 394(Pt 2):449-57. PubMed ID: 16232121 [TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. Patrick DM; Leone AK; Shellenberger JJ; Dudowicz KA; King JM BMC Physiol; 2006 Feb; 6():2. PubMed ID: 16504032 [TBL] [Abstract][Full Text] [Related]
10. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells. Thangasamy A; Rogge J; Ammanamanchi S J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182 [TBL] [Abstract][Full Text] [Related]
11. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers. Wang MH; Yao HP; Zhou YQ Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080 [TBL] [Abstract][Full Text] [Related]
12. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells. Xu XM; Wang D; Shen Q; Chen YQ; Wang MH Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo. Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. Wang MH; Wang D; Chen YQ Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733 [TBL] [Abstract][Full Text] [Related]
16. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Feres KJ; Ischenko I; Hayman MJ Oncogene; 2009 Jan; 28(2):279-88. PubMed ID: 18836480 [TBL] [Abstract][Full Text] [Related]
17. RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant. Eckerich C; Schulte A; Martens T; Zapf S; Westphal M; Lamszus K J Neurochem; 2009 May; 109(4):969-80. PubMed ID: 19519771 [TBL] [Abstract][Full Text] [Related]
18. Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells. Xia Y; Lian S; Khoi PN; Yoon HJ; Han JY; Chay KO; Kim KK; Jung YD Int J Oncol; 2015 Apr; 46(4):1835-43. PubMed ID: 25625479 [TBL] [Abstract][Full Text] [Related]
19. Significance of the entire C-terminus in biological activities mediated by the RON receptor tyrosine kinase and its oncogenic variant RON160. Lu Y; Yao HP; Wang MH J Exp Clin Cancer Res; 2008 Oct; 27(1):55. PubMed ID: 18950514 [TBL] [Abstract][Full Text] [Related]
20. Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence. Côté M; Miller AD; Liu SL Biochem Biophys Res Commun; 2007 Aug; 360(1):219-25. PubMed ID: 17588532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]